Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 9

Results For "Customer"

1245 News Found

Boston Scientific to acquire Penumbra in $14.5 billion deal
News | January 17, 2026

Boston Scientific to acquire Penumbra in $14.5 billion deal

Penumbra projects fourth-quarter revenue growth of 21.4% to 22.0%, with full-year 2025 revenue expected to reach approximately $1.4 billion


Vetter advances next-gen syringe closure system towards 2027 launch
Medical Device | January 16, 2026

Vetter advances next-gen syringe closure system towards 2027 launch

The updated closure system introduces intuitive handling, innovative functionality and a premium design compatible with a wide range of syringe formats


Thermo Fisher and NVIDIA team up to supercharge labs with AI
Digitisation | January 14, 2026

Thermo Fisher and NVIDIA team up to supercharge labs with AI

Artificial intelligence coupled with laboratory automation will transform how scientific work is performed


Zealand Pharma taps Denmark’s supercomputer to supercharge drug discovery
R&D | January 14, 2026

Zealand Pharma taps Denmark’s supercomputer to supercharge drug discovery

Gefion, powered entirely by renewable energy, boasts more than 1,500 NVIDIA GPUs


Firstsource acquires TeleMedik
Healthcare | January 14, 2026

Firstsource acquires TeleMedik

The acquisition combines Firstsource’s market-leading AI and automation capabilities with TeleMedik’s operational footprint in Puerto Rico


Dr. Reddy’s launches first generic equivalent of extra-strength Pataday in US
News | January 14, 2026

Dr. Reddy’s launches first generic equivalent of extra-strength Pataday in US

Dr. Reddy’s Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% is an antihistamine eye drop, indicated for the temporary relief of itchy eyes due to pollen, ragweed, grass, animal hair and dander


Aragen slashes drug development time with CHOMax platform
News | January 12, 2026

Aragen slashes drug development time with CHOMax platform

CHOMax integrates cell line development, process development, analytics, and GMP manufacturing under robust quality processes


PharmaForceIQ acquires Aktana, launches first “optichannel-in-a-box” platform for pharma
News | January 12, 2026

PharmaForceIQ acquires Aktana, launches first “optichannel-in-a-box” platform for pharma

The integration unifies brand and field strategy, drives executional alignment, and delivers immediate impact measurement


NAMSA expands US footprint with Labcorp medical device testing acquisition
News | January 12, 2026

NAMSA expands US footprint with Labcorp medical device testing acquisition

The deal brings Labcorp’s U.S. portfolio—including biocompatibility, microbiological, and analytical testing, as well as preclinical research—under NAMSA’s roof


IMCD opens beauty, personal Care laboratory in California
R&D | January 09, 2026

IMCD opens beauty, personal Care laboratory in California

The new facility offers an expanded laboratory alongside meeting areas dedicated to development meetings, formulation workshops, and brainstorming sessions